Anti-CD45 Monoclonal Antibody, Cytarabine, Cyclophosphamide, and Total-Body Irradiation With or Without Alemtuzumab in Treating Patients Undergoing a Donor Stem Cell Transplant For Advanced Leukemia or Other Hematologic Cancer

This study is currently recruiting participants.

Study NCT00601380 Information provided by National Cancer Institute (NCI)

First Received: January 15, 2008 Last Updated: June 9, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	April 2011 (Final data collection date for primary outcome measure)